Corbus Pharmaceuticals Holdings (CRBP) Change in Receivables (2017 - 2018)
Corbus Pharmaceuticals Holdings' (CRBP) quarterly Change in Receivables came in at -$6.2 million in Q2 2018, little changed quarter-over-quarter from -$6.2 million in Q1 2018.
Corbus Pharmaceuticals Holdings (CRBP) Change in Receivables (2017 - 2018) Analysis & Trends
Corbus Pharmaceuticals Holdings' Change in Receivables history runs 2 years deep, the most recent figure standing at -$6.2 million for Q2 2018.
- On a quarterly basis, Change in Receivables changed N/A year-over-year to -$6.2 million in Q2 2018; TTM through Sep 2019 was -$6.2 million, a 51.92% increase from a year earlier, with the FY2019 full-year figure at -$5.0 million, up 60.0% from the prior year.
- Change in Receivables held at -$6.2 million in Q2 2018 per CRBP's latest filing, from -$6.2 million in the prior quarter.
- Across five years, Change in Receivables topped out at $500000.0 in Q3 2017 and bottomed at -$6.2 million in Q1 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Corbus Pharmaceuticals Holdings | 164.14 Mn | 136.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | -6.25 Mn |
| Jun 30, 2018 | -6.25 Mn |
| Mar 31, 2018 | -6.25 Mn |
| Mar 31, 2018 | -6.25 Mn |
| Dec 31, 2017 | -500,000.00 |
| Dec 31, 2017 | -500,000.00 |
| Sep 30, 2017 | 500,000.00 |
| Sep 30, 2017 | 500,000.00 |
| Mar 31, 2017 | -1.00 Mn |
| Mar 31, 2017 | -1.00 Mn |